A study published Friday in Nature Communications demonstrates that an ultra-flexible penetrating electrode array can stimulate the cochlear nucleus with high spatial resolution and stable tonotopic precision for over four months, outperforming the surface arrays that have limited auditory brainstem implants for decades.
Researchers at Shanghai Jiao Tong University School of Medicine and the Chinese Academy of Sciences implanted the device, dubbed uFINE, in normal-hearing rats. The array mapped frequency tuning from 0.5 to 32 kilohertz across the cochlear nucleus and inferior colliculus. Selective stimulation evoked responses in the inferior colliculus that closely matched natural acoustic tonotopy, with tuning widths comparable to tone-evoked responses, the study reports.
Conventional auditory brainstem implants rely on surface electrodes that sit on the brainstem. They offer limited spatial resolution and restricted access to the tonotopic map—the spatial arrangement of frequency processing—yielding highly variable outcomes, from poor to moderate hearing restoration. The penetrating design of uFINE overcomes this by reaching specific neural populations within the cochlear nucleus.
Stability remained a central question for penetrating interfaces, which risk tissue damage and gliosis. The team tracked the implants for 136 days. They observed minimal gliosis and stable electrophysiological thresholds throughout the period. “These findings demonstrate that uFINE enables high-resolution, tonotopically precise, and long-term stable CN stimulation across a broad frequency range with minimal tissue disruption,” the authors wrote in the paper.
The work also revealed a plasticity effect. Daily sequential stimulation of the cochlear nucleus followed by the inferior colliculus progressively shifted the location of the CN-evoked IC response peak toward the targeted IC stimulation site. The researchers attribute this to use-dependent plasticity, suggesting the nervous system adapts to the stimulation pattern over time.

Funding for the research came from the National Natural Science Foundation of China, the National Key Technology Research and Development Program, the Shanghai Municipal Science and Technology Major Project, and the Shanghai Pujiang Program.
Zeyu Wang, Guangyuan Chen, Chengyao Wang, Chi Ren, and Zhengtuo Zhao are listed as inventors on a Chinese patent application covering the ultra-flexible penetrating electrode array. Zhengtuo Zhao is a co-founder of and holds equity in Shanghai StairMed Technology Co., Ltd., which assisted with electrode assembly.
Shanghai Jiao Tong University School of Medicine traces its roots to 1952 as Shanghai Second Medical College, formed from the medical schools of Aurora University, St. John’s University and Tong De Medical College. It became a university in 1985 and merged with Shanghai Jiao Tong University in 2005. Its clinical medicine discipline has ranked first nationally in Ministry of Education evaluations and placed 55th globally in the 2025 U.S. News & World Report ranking.
| Parameter | Conventional Surface ABI | uFINE Penetrating Array (Study Findings) |
|---|---|---|
| Spatial Resolution | Limited | High-density, frequency-selective |
| Tonotopic Access | Restricted | 0.5–32 kHz mapped in CN and IC |
| Chronic Stability | Variable outcomes | Stable >136 days, minimal gliosis |
| IC Tuning Widths | Broad, variable | Comparable to acoustic tone responses |
The study was published online November 22, 2026. The corresponding authors are Chi Ren, Zhengtuo Zhao, and Hao Wu. Jinxi Pan and Bodi Liu contributed equally as first authors.